Mutation screening of splice sites of exon12 of BRCA2 in breast cancer
-
- Englisch ausgewählt
Fr. 83.90
inkl. gesetzl. MwSt.,
Beschreibung
Produktdetails
Einband
Taschenbuch
Erscheinungsdatum
24.03.2015
Verlag
LAP LAMBERT Academic PublishingSeitenzahl
152
Maße (L/B/H)
22/15/1 cm
Gewicht
244 g
Sprache
Englisch
ISBN
978-3-659-43722-9
Several breast cancer susceptibility genes had been identified; among those are BRCA1 and BRCA2. Breast cancer is the predominant phenotype associated with mutations in BRCA1 and BRCA2 genes. However, the rate of mutations within the coding regions of the breast cancer susceptibility gene BRCA2 does not fairly explain the pathogenecity of the disease, nor accounting for all disease causing mutations. The aim of this study was to detect mutations that might affect the splicing of exon12 of the BRCA2 gene and thus modulating the functions of BRCA2¿12 variant in particular and its contribution to the overall biological functions of BRCA2 in DNA repair and tumor suppression. The structural and functional consequences for the corresponding protein will help to understand the role played by different BRCA2 variants in breast cancer.
Kundinnen und Kunden meinen
Verfassen Sie die erste Bewertung zu diesem Artikel
Helfen Sie anderen Kund*innen durch Ihre Meinung